Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03244072 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery

StatusNot Yet Recruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jun 1, 2026 to Jun 1, 2027
    • Eligibility criteria expanded, about 2 words
  2. Primary completion date: Oct 2025 to Oct 2030
    • Start date: Jun 1, 2025 to Jun 1, 2026
    • Study completion date: Oct 2025 to Oct 2031
    v11
  3. Start date: Jun 1, 2024 to Jun 1, 2025v10
  4. Start date: Jan 1, 2023 to Jun 1, 2024v9
  5. Enrollment target: 15000 to 60000
    • Eligibility criteria expanded, about 2 words
    v8
Show 6 earlier versionsHide 6 earlier versions
  1. Start date: Jul 1, 2022 to Jan 1, 2023v7
  2. Primary and study completion dates: Oct 2020 to Oct 2025
    • Start date: Jul 1, 2020 to Jul 1, 2022
    v6
  3. Start date: Oct 1, 2019 to Jul 1, 2020v5
  4. Primary and study completion dates: Oct 2019 to Oct 2020
    • Start date: Oct 1, 2018 to Oct 1, 2019
    v4
  5. Start date: Apr 1, 2018 to Oct 1, 2018v3
  6. Start date: Oct 2017 to Apr 1, 2018v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Intracameral injection of 0.1% moxifloxacin solution after cataract surgery to prevent endophthalmitis
Trial Details
NCT Number NCT03244072
Lead Sponsor Jason Ahee, M.D.
Conditions
(from sponsor)		 Endophthalmitis
Related terms Endophthalmitis
Enrollment 60,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov